Renaissance Technologies’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.35M | Buy |
+676,900
| New | +$6.35M | 0.01% | 1368 |
|
|
2025
Q1 | – | Sell |
-98,700
| Closed | -$1.15M | – | 3720 |
|
|
2024
Q4 | $1.15M | Buy |
+98,700
| New | +$1.15M | ﹤0.01% | 2421 |
|
|
2024
Q3 | – | Sell |
-38,700
| Closed | -$866K | – | 3775 |
|
|
2024
Q2 | $866K | Buy |
+38,700
| New | +$866K | ﹤0.01% | 2400 |
|
|
2024
Q1 | – | Sell |
-13,397
| Closed | -$408K | – | 3953 |
|
|
2023
Q4 | $408K | Buy |
+13,397
| New | +$408K | ﹤0.01% | 2864 |
|
|
2023
Q2 | – | Sell |
-16,554
| Closed | -$617K | – | 4162 |
|
|
2023
Q1 | $617K | Buy |
+16,554
| New | +$617K | ﹤0.01% | 2774 |
|
|
2022
Q3 | – | Sell |
-119,600
| Closed | -$6.19M | – | 4302 |
|
|
2022
Q2 | $6.19M | Buy |
+119,600
| New | +$6.19M | 0.01% | 1403 |
|
|
2020
Q3 | – | Sell |
-41,000
| Closed | -$862K | – | 3581 |
|
|
2020
Q2 | $862K | Buy |
+41,000
| New | +$862K | ﹤0.01% | 2616 |
|
|
2020
Q1 | – | Sell |
-36,700
| Closed | -$538K | – | 3677 |
|
|
2019
Q4 | $538K | Buy |
+36,700
| New | +$538K | ﹤0.01% | 2879 |
|
|
2019
Q3 | – | Sell |
-164,600
| Closed | -$2.7M | – | 3614 |
|
|
2019
Q2 | $2.7M | Buy |
+164,600
| New | +$2.7M | ﹤0.01% | 2175 |
|
|
2019
Q1 | – | Sell |
-228,000
| Closed | -$3.11M | – | 3617 |
|
|
2018
Q4 | $3.11M | Buy |
+228,000
| New | +$3.11M | ﹤0.01% | 2012 |
|
|
2017
Q3 | – | Sell |
-19,200
| Closed | -$307K | – | 3308 |
|
|
2017
Q2 | $307K | Buy |
+19,200
| New | +$307K | ﹤0.01% | 2902 |
|